Acerus Pharmaceuticals Stock Forecast, Price & News

Acerus Pharmaceuticals (OTCMKTS:ASPCF) Frequently Asked Questions

How has Acerus Pharmaceuticals' stock been impacted by Coronavirus (COVID-19)?

Acerus Pharmaceuticals' stock was trading at $0.0380 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ASPCF shares have decreased by 21.1% and is now trading at $0.03.
View which stocks have been most impacted by COVID-19.

Are investors shorting Acerus Pharmaceuticals?

Acerus Pharmaceuticals saw a drop in short interest in December. As of December 31st, there was short interest totaling 800 shares, a drop of 97.2% from the December 15th total of 28,400 shares. Based on an average trading volume of 11,900 shares, the days-to-cover ratio is presently 0.1 days.
View Acerus Pharmaceuticals' Short Interest.

When is Acerus Pharmaceuticals' next earnings date?

Acerus Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Wednesday, March 9th 2022.
View our earnings forecast for Acerus Pharmaceuticals.

Who are Acerus Pharmaceuticals' key executives?

Acerus Pharmaceuticals' management team includes the following people:

• Edward Gudaitis, President, CEO & Non-Independent Director
• Bob Motz, Chief Financial Officer
• Christopher Sorli, Chief Medical Officer
• Philippe Savard, Secretary, Vice President & General Counsel
• Kevin Hickey, Senior Vice President-US Commercial

Who are some of Acerus Pharmaceuticals' key competitors?

Some companies that are related to Acerus Pharmaceuticals include TFF Pharmaceuticals (TFFP), InflaRx (IFRX), Humanigen (HGEN), CM Life Sciences III (CMLT), Longeveron (LGVN), Frequency Therapeutics (FREQ), UroGen Pharma (URGN), CorMedix (CRMD), OptiNose (OPTN), DURECT (DRRX), Procaps Group S.A (PROC), Vincerx Pharma (VINC), Syros Pharmaceuticals (SYRS), Neoleukin Therapeutics (NLTX) and Larimar Therapeutics (LRMR).
View all of ASPCF's competitors.

What is Acerus Pharmaceuticals' stock symbol?

Acerus Pharmaceuticals trades on the OTCMKTS under the ticker symbol "ASPCF."

How do I buy shares of Acerus Pharmaceuticals?

Shares of ASPCF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Acerus Pharmaceuticals' stock price today?

One share of ASPCF stock can currently be purchased for approximately $0.03.

How much money does Acerus Pharmaceuticals make?

Acerus Pharmaceuticals has a market capitalization of $46.13 million and generates $1.09 million in revenue each year. The company earns $-24.42 million in net income (profit) each year or ($0.02) on an earnings per share basis.

How many employees does Acerus Pharmaceuticals have?

Acerus Pharmaceuticals employs 147,000 workers across the globe.

What is Acerus Pharmaceuticals' official website?

The official website for Acerus Pharmaceuticals is www.aceruspharma.com.

Where are Acerus Pharmaceuticals' headquarters?

Acerus Pharmaceuticals is headquartered at 2486 Dunwin Drive, Mississauga A6, L5L 1J9.

How can I contact Acerus Pharmaceuticals?

Acerus Pharmaceuticals' mailing address is 2486 Dunwin Drive, Mississauga A6, L5L 1J9. The company can be reached via phone at (416) 679-0771, via email at [email protected], or via fax at 905-569-1809.